|
Shire pulls the plug on MPS-III LSD candidate SHP610
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 02, 2016 10:30AM
|
|
Share Price
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 12, 2016 02:14PM
|
|
Sept 21 AGM amended to be Annual General and Special Meeting
|
1
|
BIOASIS TECHNOLOGIES INC
|
Aug 01, 2017 01:40PM
|
|
Selective vs. Non-Selective BET Inhibitors for PAH
|
5
|
Resverlogix Corp.
|
Nov 09, 2019 09:13PM
|
|
Seeking Alpha news on Resverlogix's lead product candidate for CV disease
|
4
|
Resverlogix Corp.
|
Nov 11, 2015 12:08PM
|
|
Seeking Alpha articles
|
10
|
Resverlogix Corp.
|
Aug 05, 2017 11:27AM
|
|
Second ZEN003694 Trial now listed on ClinicalTrials.gov
|
5
|
Zenith Epigenetics
|
Mar 20, 2016 09:12PM
|
|
Sangamo In Vivo Gene Editing for Enzyme/Protein Replacement Therapy
|
1
|
BIOASIS TECHNOLOGIES INC
|
Nov 17, 2017 10:42AM
|
|
Same story, different conference
|
2
|
Resverlogix Corp.
|
May 13, 2017 12:21PM
|
|
Safety and Efficacy at 9 months
|
6
|
Resverlogix Corp.
|
Aug 12, 2016 10:22AM
|
|
Safety and Effect of Oral RVX000222 in Subjects With Fabry Disease
|
5
|
Resverlogix Corp.
|
Jul 25, 2017 10:42AM
|
|
SAB meeting and Corporate Presentation
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jul 09, 2018 12:12PM
|
|
SAB and data
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 27, 2018 09:56AM
|
|
RVX-208 vs. CETP inhibitors
|
4
|
Resverlogix Corp.
|
Aug 18, 2015 04:10PM
|
|
RVX-208 Moderated Poster Presentation at IAS 2015 May 26, 2015
|
2
|
Resverlogix Corp.
|
May 18, 2015 01:49PM
|
|
RVX-208 and Rosuvastatin Patent
|
8
|
Resverlogix Corp.
|
Dec 12, 2016 05:01PM
|
|
RVX-208 Ameliorates Peridontal Bone Loss
|
8
|
Resverlogix Corp.
|
May 24, 2018 10:17AM
|
|
RVX Webcast 9/10 10:25 AM (EST) at Rodman and Renshaw
|
4
|
Resverlogix Corp.
|
Sep 09, 2015 10:58PM
|
|
RVX Webcast 9/10 10:25 AM (EST) at Rodman and Renshaw
|
4
|
Resverlogix Corp.
|
Sep 04, 2015 03:05PM
|
|
RVX tweet from Nov 7th
|
7
|
Resverlogix Corp.
|
Nov 12, 2016 03:44PM
|
